1. Home
  2. NWN vs SRPT Comparison

NWN vs SRPT Comparison

Compare NWN & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NWN

Northwest Natural Holding Company

HOLD

Current Price

$46.77

Market Cap

2.0B

Sector

Utilities

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$21.52

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWN
SRPT
Founded
1859
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.4B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
NWN
SRPT
Price
$46.77
$21.52
Analyst Decision
Buy
Hold
Analyst Count
2
28
Target Price
$49.50
$25.68
AVG Volume (30 Days)
241.2K
2.7M
Earning Date
02-27-2026
02-25-2026
Dividend Yield
4.18%
N/A
EPS Growth
20.18
N/A
EPS
2.47
N/A
Revenue
$1,266,082,000.00
$2,413,715,000.00
Revenue This Year
$15.18
$13.99
Revenue Next Year
$6.55
N/A
P/E Ratio
$19.04
N/A
Revenue Growth
11.27
47.15
52 Week Low
$38.94
$10.42
52 Week High
$49.63
$120.05

Technical Indicators

Market Signals
Indicator
NWN
SRPT
Relative Strength Index (RSI) 50.37 49.28
Support Level $46.35 $20.10
Resistance Level $47.16 $21.88
Average True Range (ATR) 0.78 1.38
MACD 0.06 -0.16
Stochastic Oscillator 58.31 34.08

Price Performance

Historical Comparison
NWN
SRPT

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: